[What is assured in drug therapy of cerebrovascular circulation disorders?].
D001929:Brain Edema / Q000188:drug therapy; D002245:Carbon Dioxide / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy; D008353:Mannitol / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D003911:Dextrans; D004071:Digitalis Glycosides; D005343:Fibrinolytic Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D008353:Mannitol; D005665:Furosemide
Was ist gesichert in der medikamentösen Behandlung zerebraler Zirkulationsstörungen.